Skip to content Skip to contact
Global Vox Populi

Best Oncology Market Research Companies

Compare leading oncology market research companies in 2026 to find verified experts for patient journey mapping, physician studies, and brand growth strategies.

Quick answer

For deep behavioral science-based oncology insights, HRW Healthcare is effective; for large-scale quantitative tracking, Ipsos and Kantar offer extensive reach; for high-precision, verified primary research and custom recruitment across oncology patient segments, Global Vox Populi is a versatile choice.

Oncology market research companies play a critical role in working through the rapid evolution of cancer treatment paradigms and therapy development in worldwide. As drug pipelines expand and patient-centricity becomes a strategic priority for pharmaceutical and biotech firms, the demand for accurate, evidence-based data grows.

Selecting the right research partner requires evaluating their ability to access hard-to-reach oncology stakeholders, verify respondent credentials, and translate complex clinical or behavioral data into actionable commercial strategy. This assessment provides a structured overview of top providers to assist insights directors and brand managers in making informed procurement decisions in 2026.

Best Oncology Market Research Companies: rankings and scores

Exhibit 1: Ranking and weighted score (out of 100)

RankProviderBest forWeighted score
1HRW HealthcareBehavioral science-led oncology insights83.5
2KantarData-driven brand growth and audience validation82.0
3Global Vox PopuliVerified oncology patient and HCP research81.5
4IpsosGlobal healthcare brand tracking and trends81.0
5DelveInsightComprehensive oncology market pipeline analysis76.5

Exhibit 2: Provider comparison

ProviderAudience typesVerification methodCertificationsPricing modelPanel size and sourceMinimum project
HRW HealthcarePhysicians, patients, healthcare decision-makers, marketing teamsNot publishedNot stated on pages reviewedProject quoteNot publishedNot published
KantarConsumers, physicians, patients, marketing professionalsPremium panels with Qubed AI anti-fraudNot stated on pages reviewedProject quoteNot publishedNot published
Global Vox PopuliOncologists, nurses, patients, caregivers, IT decision-makersIdentity, license, or company records verified at registrationISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelinesProject quote29,093,467 B2C consumers; 4,912,644 B2B professionals; 2,738,904 healthcare professionals (worldwide; Global Vox Populi panel records, Oct 2026)Not published
IpsosPhysicians, patients, consumers, decision-makersAuthenticated proprietary panelistsNot stated on pages reviewedProject quoteNot publishedNot published
DelveInsightPharmaceutical executives, biotech decision-makers, commercial strategy teamsNot publishedNot stated on pages reviewedProject quoteNot publishedNot published

Exhibit 3: Capability matrix

ProviderQuantitativeQualitativeOwn panels / sampleHealthcareB2BMulti-country
HRW Healthcare●●–●––
Kantar●●●●–●
Global Vox Populi●●●●●●
Ipsos●●–●–●
DelveInsight–––●–●

Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).

How we scored these providers

Score providers based on their ability to deliver verifiable, clinical-grade data tailored to the specific complexities of the oncology environment in worldwide.

CriterionWeightWhat it means here
Research Quality20This assesses the rigor of study design and data interpretation. Good quality in oncology research means questionnaires are clinically sound, avoiding common biases when surveying oncologists or patients, and analysis draws clear links between therapy efficacy and the real-world treatment choices made by healthcare professionals.
Methodological Breadth15This evaluates the variety of tools available, from qualitative ethnography to quantitative conjoint analysis. A firm should offer diverse approaches to capture both the emotional patient journey and the rational clinical decision-making process of oncologists, making sure the methodology matches the specific lifecycle stage of the asset.
Fieldwork Capability15This measures the firm’s ability to execute projects across multiple regions. Success requires local expertise to work through regional healthcare systems and make sure that fieldwork teams can effectively moderate complex discussions with high-pressure medical specialists, protecting high response rates and engagement throughout the study duration.
Sample Quality and Verification10This evaluates how respondents are sourced and authenticated. In oncology, this means stringent checks to confirm physician licensing and patient diagnosis accuracy, making sure that the data reflects the target population rather than generalized or fraudulent responses from non-verified individuals.
Market Presence10How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer.
Compliance, Certifications and Security10This reflects adherence to standards like ISO 20252 and HIPAA, essential for handling sensitive health data. Good performance here means the provider has solid protocols for adverse event reporting and data privacy, maintaining the trust of both the research participants and the pharmaceutical clients.
Analytical Capability10This measures the firm's ability to extract commercial meaning from complex clinical datasets. A strong partner goes beyond simple charts, offering strategic recommendations that help brand teams understand market positioning, competitive threats, and the specific drivers of prescribing behavior within the oncology space.
Client Service and Speed5This assesses responsiveness and project management quality. In oncology, where clinical data updates quickly, researchers must deliver insights with urgency while remaining available for iterative discussions, making sure that the research remains relevant as market conditions or study parameters shift during the project life cycle.
Pricing and Feasibility Transparency5This evaluates the honesty of the provider regarding project timelines and costs. A transparent firm provides clear feasibility assessments for low-incidence oncology segments early on, avoiding over-promising on sample sizes and making sure that the final output provides value relative to the investment made by the client.

Why these weights. For full-service work, the quality of the research design decides whether the answer can be trusted, so it leads (20). Methods and fieldwork (15 each) decide whether that design can be executed in this market. Sample quality, compliance and analysis (10 each) separate good partners from adequate ones; service and pricing transparency (5 each) are tie-breakers. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.

Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.

Provider profiles: oncology market research companies worldwide

01

HRW Healthcare: best for behavioral science-led oncology insights

hrwhealthcare.com

83.5out of 100Rank 1 of 5
HRW Healthcare homepage
HRW Healthcare homepage, October 2026

Strongest fitBrand teams seeking to understand the psychological and behavioral drivers behind oncologist prescribing patterns.

HRW Healthcare provides comprehensive market research by integrating behavioral and data science to understand the underlying drivers of human behavior. Their multidisciplinary teams work across the global oncology environment, focusing on both the commercial and scientific aspects of product lifecycles.

The firm maintains specialized teams such as HRW Shift, which focuses on behavior change, and an internal data science unit. This approach enables them to move beyond surface-level data, providing clients with evidence-based recommendations for brand strategy and patient engagement.

Scorecard: 83.5 out of 100
CriterionWeightScoreEvidence and date
Research Quality209/10hrwhealthcare.com (6 pages reviewed), Oct 2026
Methodological Breadth159/10hrwhealthcare.com (6 pages reviewed), Oct 2026
Fieldwork Capability158/10hrwhealthcare.com (6 pages reviewed), Oct 2026
Sample Quality and Verification108/10hrwhealthcare.com (6 pages reviewed), Oct 2026
Market Presence107/10Google results for this search and company size, Oct 2026
Compliance, Certifications and Security108/10hrwhealthcare.com (6 pages reviewed), Oct 2026
Analytical Capability109/10hrwhealthcare.com (6 pages reviewed), Oct 2026
Client Service and Speed58/10hrwhealthcare.com (6 pages reviewed), Oct 2026
Pricing and Feasibility Transparency58/10hrwhealthcare.com (6 pages reviewed), Oct 2026
Weighted score10083.5

Core services

  • Behavioral Science Research: Application of behavioral science through HRW Shift to uncover deep motivations of physicians and patients.
  • Data Science Integration: Advanced quantitative solutions including demand forecasting, segmentation, and complex attitudinal data analysis.
  • Qualitative Research: Proprietary qualitative methodologies that explore the 'why' behind treatment choices and patient experiences.
  • Patient Journey Research: Research focused on mapping the patient experience to optimize brand strategy and improve adherence.

Strengths

  • Behavioral Science Expertise: Uses a dedicated behavioral science team to provide deeper insights into stakeholder decision-making than standard research.
  • Integrated Data Science: Combines behavioral insights with rigorous quantitative data to create a holistic view of the oncology market.
  • Patient-Centric Approach: Translates patient stories into actionable data to influence prescribing and improve healthcare experiences.

Innovation and technology

  • HRW Shift: A specialized behavioral science team that creates evidence-based 'nudges' and strategies for behavior change.
  • Data Fusion: Integration of behavioral science with data science to model complex variables affecting product uptake.

Impact on businesses

  • Strategic Change: Delivers recommendations that drive measurable behavior change among stakeholders and improve commercial outcomes.
  • Brand Optimization: Refines communications and targeting strategies to maximize brand impact across the product life cycle.

Types of research

  • Behavioral science studies
  • Quantitative segmentation
  • Patient journey mapping
  • Concept testing
  • Demand forecasting

Industries covered

  • Oncology
  • Biotechnology
  • Pharmaceuticals
  • Healthcare

Why it may fit your brief

The firm is ideal for complex behavioral questions. For clients needing strictly transactional or high-volume survey data without behavioral modeling, a generalist research firm may be more cost-effective.

02

Kantar: best for data-driven brand growth and audience validation

kantar.com

82.0out of 100Rank 2 of 5
Kantar homepage
Kantar homepage, October 2026

Strongest fitPharmaceutical brands focusing on large-scale digital audience validation and brand equity measurement.

Kantar provides extensive research services, using a massive footprint of consumer and professional data. Their health division focuses on understanding market dynamics, brand growth, and patient behaviors through sophisticated analytics and multi-market research frameworks.

With proprietary panels and advanced anti-fraud technology, the firm protects high-quality data for critical business decisions. Their approach integrates survey data with third-party sources to provide a holistic view of the market environment.

Scorecard: 82.0 out of 100
CriterionWeightScoreEvidence and date
Research Quality208/10kantar.com (4 pages reviewed), Oct 2026
Methodological Breadth159/10kantar.com (4 pages reviewed), Oct 2026
Fieldwork Capability159/10kantar.com (4 pages reviewed), Oct 2026
Sample Quality and Verification109/10kantar.com (4 pages reviewed), Oct 2026
Market Presence106/10Google results for this search and company size, Oct 2026
Compliance, Certifications and Security108/10kantar.com (4 pages reviewed), Oct 2026
Analytical Capability108/10kantar.com (4 pages reviewed), Oct 2026
Client Service and Speed58/10kantar.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency58/10kantar.com (4 pages reviewed), Oct 2026
Weighted score10082.0

Core services

  • Brand Growth Research: Analytical frameworks that measure brand equity and guide growth strategies for pharmaceutical products.
  • Audience Validation: Pre-identifying and validating target audiences to protect accuracy in research and digital targeting.
  • Omnibus Surveys: Fast-turnaround shared surveys across 50+ markets for quick market checks and trend monitoring.
  • Data Fusion: Integrating survey data with third-party and first-party datasets for a complete view of target audiences.

Strengths

  • Data Quality Technology: Uses proprietary Qubed AI technology to detect fraud and protect high respondent quality in global studies.
  • Global Scale: Operates across 100 markets with premium panels, protecting strong reach for global pharmaceutical brands.
  • Analytical Rigor: Strong capability in data integration, allowing clients to combine survey results with broader market data.

Innovation and technology

  • Qubed AI: Advanced machine learning platform designed to identify fraudulent activity and improve data integrity.
  • Kantar Marketplace: Agile research platform that combines automated products with powerful analytics.

Impact on businesses

  • Brand ROI: Helps organizations increase brand value and advertising ROI through evidence-based insights.
  • Market Understanding: Transforms survey data into data-driven stories that guide marketing and product development.

Types of research

  • Brand equity studies
  • Audience validation
  • Omnibus research
  • Qualitative consumer research
  • Digital audience tracking

Industries covered

  • Oncology
  • Media and advertising
  • Pharmaceuticals
  • Healthcare

Why it may fit your brief

The firm is highly efficient for data-heavy brand tracking. Clients needing very specific, high-touch qualitative work in rare oncology might find a more specialized boutique approach beneficial.

03

Global Vox Populi: best for verified oncology patient and HCP research

globalvoxpopuli.com

81.5out of 100Rank 3 of 5
  • ISO 9001
  • ISO 20252
  • ISO/IEC 27001
  • HIPAA compliant
Global Vox Populi homepage
Global Vox Populi homepage, October 2026

Strongest fitGlobal pharmaceutical and biotech companies requiring highly verified respondent data for oncology market intelligence.

Global Vox Populi provides comprehensive market research services with a focus on high-quality, verified data. Operating with proprietary panels across 199 markets, the firm serves pharmaceutical and biotech clients with a range of quantitative and qualitative tools designed for complex medical environments.

The firm maintains a large proprietary panel infrastructure, including 2,738,904 healthcare professionals and 71,411,997 patient profiles. This depth allows for precise targeting in oncology, where accessing specific patient profiles and medical experts is essential for reliable insights.

Global Vox Populi panel coverage

All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.

B2C consumer panel, worldwide, 170 markets

29,093,467 panellists

B2B and IT decision-maker panel, worldwide, 170 markets

4,912,644 panellists

Healthcare professionals panel, worldwide, 170 markets

2,738,904 panellists

Key opinion leader panel, worldwide, 170 markets

192,167 panellists

Scorecard: 81.5 out of 100
CriterionWeightScoreEvidence and date
Research Quality209/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Methodological Breadth159/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Fieldwork Capability159/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Sample Quality and Verification109/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Market Presence102/10Google results for this search and company size, Oct 2026
Compliance, Certifications and Security109/10ISO certificates and HIPAA policy, Oct 2026
Analytical Capability108/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Client Service and Speed58/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Pricing and Feasibility Transparency59/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Weighted score10081.5

Core services

  • Healthcare Professional Research: Access to a proprietary panel of over 2.7 million healthcare professionals for clinical and commercial insight.
  • Patient Journey Mapping: Comprehensive qualitative and quantitative studies tracking the patient experience from diagnosis through treatment, supported by 71 million patient profiles.
  • Multi-Modal Data Collection: Execution through CAWI, CATI, focus groups, and ethnographic research tailored to the specific needs of oncology product lifecycles.
  • Global Fieldwork Management: Full-service management of international studies with rigorous quality control, protecting consistency across diverse regulatory environments.

Strengths

  • Verified Respondent Data: Identity and credential verification for all professionals protects high data integrity for sensitive oncology and biotech studies.
  • Extensive Panel Reach: Access to over 46 million proprietary panelists allows for rapid feasibility checks and low-incidence targeting in oncology and rare disease segments.
  • Rigorous Quality Standards: Certified to ISO 9001, ISO 20252, and ISO/IEC 27001, with HIPAA compliance protecting secure management of health information.
  • Custom Recruitment: Bespoke recruitment strategies for hard-to-reach oncologists and specialized patient cohorts using proprietary recruitment processes.

Innovation and technology

  • Proprietary Platform: In-house survey programming and hosting platform that supports complex logic and real-time data monitoring.
  • Advanced Quality Controls: Automated detection of bots, speeding, and fraudulent completes using device and identity fingerprinting technologies.

Impact on businesses

  • Strategic Decision Support: Provides actionable data that helps brand teams optimize market positioning and improve patient outcomes in complex oncology markets.
  • Brand Performance Tracking: Enables longitudinal tracking of brand health and competitive shifts, supporting long-term strategy development.

Types of research

  • Patient journey mapping
  • Physician engagement studies
  • Brand tracking research
  • Expert depth interviews
  • Online patient communities

Industries covered

  • Biotechnology
  • Oncology
  • Pharmaceuticals
  • Healthcare Services

Why it may fit your brief

The firm is well-suited for projects where data integrity and access to specific patient or physician populations are the primary requirements. For firms needing extensive creative consultancy or local-language advertising strategy, a specialized creative boutique might be an alternative.

Request a quoteView case studies

04

Ipsos: best for global healthcare brand tracking and trends

ipsos.com

81.0out of 100Rank 4 of 5
Ipsos homepage
Ipsos homepage, October 2026

Strongest fitGlobal pharmaceutical companies requiring large-scale brand tracking and physician perception studies.

Ipsos provides extensive market research and public opinion expertise with a dedicated healthcare division. Their global network allows for large-scale tracking of healthcare systems, physician perceptions, and patient experiences across diverse international markets.

By using advanced technology and a deep understanding of market trends, the firm supports pharmaceutical clients in making data-driven decisions. Their research is designed to provide actionable truth, helping clients understand the societal and market factors influencing healthcare outcomes.

Scorecard: 81.0 out of 100
CriterionWeightScoreEvidence and date
Research Quality208/10ipsos.com (4 pages reviewed), Oct 2026
Methodological Breadth159/10ipsos.com (4 pages reviewed), Oct 2026
Fieldwork Capability159/10ipsos.com (4 pages reviewed), Oct 2026
Sample Quality and Verification108/10ipsos.com (4 pages reviewed), Oct 2026
Market Presence106/10Google results for this search and company size, Oct 2026
Compliance, Certifications and Security108/10ipsos.com (4 pages reviewed), Oct 2026
Analytical Capability108/10ipsos.com (4 pages reviewed), Oct 2026
Client Service and Speed58/10ipsos.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency58/10ipsos.com (4 pages reviewed), Oct 2026
Weighted score10081.0

Core services

  • Brand Health Tracking: Longitudinal tracking of brand performance and market perception among healthcare stakeholders.
  • Patient Journey Mapping: In-depth studies of the patient experience to guide marketing and product development strategies.
  • Physician Engagement: Studies designed to measure physician attitudes, prescribing behaviors, and awareness of new treatments.
  • Global Trends Analysis: Broad-scale research on healthcare system quality and public health priorities across multiple countries.

Strengths

  • Global Reach: Extensive international network allows for large-scale, consistent research across diverse healthcare systems.
  • Methodological Diversity: Offers a wide range of research tools from traditional surveys to online communities and social media analytics.
  • Actionable Insights: Focuses on turning data into actionable truth to support bolder decision-making for global brands.

Innovation and technology

  • AI Integration: Uses advanced technology and AI to deliver faster, more precise insights from global datasets.
  • Proprietary Panels: Maintains a massive network of authenticated, proprietary panelists for reliable data collection.

Impact on businesses

  • Market Strategy: Provides the data needed to make smarter, faster decisions across global pharmaceutical markets.
  • Patient Understanding: Improves organizational understanding of patient needs, leading to more effective brand strategies.

Types of research

  • Brand health tracking
  • Patient journey mapping
  • Physician surveys
  • Quantitative omnibus surveys
  • Qualitative research

Industries covered

  • Oncology
  • Pharmaceuticals
  • Healthcare
  • Consumer health

Why it may fit your brief

The firm excels in large, multi-country quantitative studies. For highly niche, ultra-rare oncology segments requiring deep qualitative expertise, a specialized boutique may provide more tailored support.

05

DelveInsight: best for comprehensive oncology market pipeline analysis

delveinsight.com

76.5out of 100Rank 5 of 5

Strongest fitBiotech firms requiring deep market intelligence and pipeline forecasting for oncology assets.

DelveInsight operates as a dedicated partner for pharmaceutical and biotech companies, concentrating on complex therapy areas including oncology. Their approach integrates market analysis with competitive intelligence to support strategic decision-making throughout the product development life cycle.

By providing deep-dive reports and specialized consulting, the firm helps clients work through shifting market trends and patient-centric needs. Their work is characterized by a focus on therapy-specific data that informs long-term brand and market entry strategies.

Scorecard: 76.5 out of 100
CriterionWeightScoreEvidence and date
Research Quality208/10Search results and industry sources, Oct 2026
Methodological Breadth157/10Search results and industry sources, Oct 2026
Fieldwork Capability157/10Search results and industry sources, Oct 2026
Sample Quality and Verification107/10Search results and industry sources, Oct 2026
Market Presence108/10Google results for this search and company size, Oct 2026
Compliance, Certifications and Security108/10Search results and industry sources, Oct 2026
Analytical Capability109/10Search results and industry sources, Oct 2026
Client Service and Speed58/10Search results and industry sources, Oct 2026
Pricing and Feasibility Transparency57/10Search results and industry sources, Oct 2026
Weighted score10076.5

Core services

  • Market Intelligence: Comprehensive analysis of global oncology market trends and competitive environments to guide strategic planning.
  • Pipeline Analysis: Detailed assessment of oncology drug development pipelines and future market opportunities.
  • Strategic Consulting: Evidence-based decision support for biotech and pharmaceutical companies regarding product launches and positioning.

Strengths

  • Oncology Specialization: Deep focus on oncology therapy areas makes sure that analysts understand the specific clinical and commercial dynamics at play.
  • Strategic Focus: Translates complex clinical data into actionable market insights that support product lifecycle management.

Innovation and technology

  • Analytical Frameworks: Proprietary research methodologies designed to forecast market shifts in rapidly evolving therapy areas.

Impact on businesses

  • Commercial Planning: Helps organizations refine their market entry and commercialization strategies for new oncology assets.

Types of research

  • Market analysis
  • Competitive intelligence
  • Pipeline forecasting
  • Strategic deep-dives

Industries covered

  • Biotechnology
  • Oncology
  • Pharmaceuticals
  • Healthcare consulting

Why it may fit your brief

The firm excels in deep-dive strategic research. Clients needing large-scale primary fieldwork or patient-level data might consider supplementing this with a primary research specialist.

How respondent verification actually works

Make sure every research participant is verified through rigorous, multi-layered identity and credential checks.

Physician Credentialing

For oncology studies, the provider must verify the physician's license and specialty against official medical databases or government registers. Ask for their specific verification process and how they handle discrepancies. A lack of this check often leads to sample contamination where non-specialists provide inaccurate treatment data.

Patient Diagnosis Verification

When surveying patients, providers should use multi-point verification, including confirmation of diagnosis or treatment history through secure, opt-in data sharing. Avoid providers that rely solely on self-reporting without secondary confirmation, as this risks including unqualified respondents in your oncology dataset.

Automated Quality Control

Leading firms use device fingerprinting, geo-location checks, and AI-driven fraud detection to identify bots and duplicate accounts. Request evidence of their anti-fraud technology and how they remove fraudulent completes before data delivery to make sure your results are based on authentic human experiences.

Panelist Re-profiling

Top-tier companies regularly update panelist profiles to reflect current professional status and health conditions. Ask about the frequency of re-profiling and how they manage consent, as outdated profiles can lead to inaccurate targeting and poor data quality in rapidly changing medical fields like oncology.

How to choose the right provider worldwide

Select a partner based on their alignment with your specific project goals, prioritizing firms with proven access to your target respondent segments.

  • Define Research Goals: Clearly distinguish between the need for broad market tracking and deep, qualitative patient journey understanding. Selecting a firm that specializes in your primary research objective is more effective than choosing a generalist.
  • Assess Recruitment Depth: Verify the provider’s ability to reach specific oncology patient or physician segments. Ask for case studies or feasibility reports that demonstrate their experience with your target group.
  • Validate Quality Protocols: Prioritize firms with documented, transparent data quality procedures. Ask for their specific approach to removing fraudulent responses and verifying professional credentials.
  • Check Regional Capabilities: Make sure the partner has strong fieldwork capabilities in the specific regions where you need data. Global scale is only useful if it is supported by local knowledge and language proficiency.
  • Evaluate Analytical Depth: Look for a partner that offers more than just data collection. Choose a firm that provides clear, strategic insights and actionable recommendations for your brand team.

Questions to ask before you commission

  1. What specific methodologies do you use to verify the credentials of oncologists in your panel?
  2. How do you protect the accuracy of diagnosis reporting for patient-level oncology studies?
  3. Can you provide a feasibility assessment for my specific target segment in worldwide?
  4. What protocols do you have for adverse event reporting during oncology market research?
  5. How does your team translate quantitative behavioral data into actionable brand strategy?
  6. How do you handle project management and communication if fieldwork challenges arise?

Common pitfalls to avoid

  • Ignoring Verification: Failing to verify physician licenses or patient diagnoses often results in low-quality data that misguides critical commercial decisions.
  • Over-reliance on Speed: Prioritizing fast turnaround times over rigorous recruitment can lead to poor sample quality and unreliable insights.
  • Neglecting Local Nuance: Assuming that global research methodologies work identically in every region without local adjustment often leads to flawed conclusions.
  • Ignoring Behavioral Drivers: Focusing only on rational prescribing data while ignoring the emotional and behavioral factors of treatment decisions limits the depth of your insight.

What a feasibility check should include

Request a detailed feasibility report that accounts for incidence rates, geographic spread, and respondent availability before launching your study.

Incidence Rate Analysis

A good feasibility check estimates the difficulty of finding your target oncology segment. Ask for a realistic assessment of how many potential respondents fit your criteria to avoid launch delays.

Geographic Feasibility

Confirm that the provider has sufficient panel members in the target regions. Make sure their recruitment strategy can meet your volume requirements across all necessary markets.

Timeline Transparency

Ask for a clear timeline that includes recruitment, fieldwork, and data cleaning phases. Reliable firms will be honest about potential bottlenecks in niche oncology segments.

Cost-Feasibility Trade-offs

Discuss how different sample sizes or methodologies impact both cost and quality. A transparent firm will help you balance your budget with your research needs.

Conclusion

Choosing the right partner from the leading oncology market research companies requires balancing the need for deep, scientifically grounded insights with the requirement for large-scale, reliable data. For high-stakes, behavioral-led strategies, firms such as HRW Healthcare offer specialized expertise that moves beyond simple data collection. For large-scale brand tracking and global consistency, partners like Ipsos and Kantar provide the scale and analytical tools necessary for established products.

For projects requiring high-precision patient and physician recruitment, Global Vox Populi provides a solid and verified proprietary panel infrastructure. By using the scorecard provided, you can align each firm’s strengths, whether in behavioral modeling, global reach, or data verification, with your project’s specific requirements. Always prioritize transparency in feasibility and verification to make sure the data you collect is suitable for long-term commercial decision-making.

Planning research worldwide? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.

Request a quote View case studies

Frequently asked questions

What are the top oncology market research companies?

Top companies in this space include specialized healthcare agencies like HRW Healthcare, as well as large-scale global providers like Ipsos, Kantar, and Global Vox Populi. The 'best' choice depends on whether you require deep behavioral science insights, large-scale quantitative tracking, or highly verified primary research and custom recruitment for niche patient segments.

How do you conduct market research for oncology drugs?

Conducting research for oncology drugs involves a blend of qualitative and quantitative methods. This includes mapping the patient journey, conducting depth interviews with oncologists to understand prescribing triggers, and using quantitative surveys to track brand performance and demand forecasting. Rigorous verification of respondent credentials is a fundamental requirement.

What is the role of market research in oncology pharmaceuticals?

Market research in oncology is essential for understanding how new therapies fit into complex treatment paradigms. It helps pharmaceutical companies identify unmet patient needs, anticipate competitive threats, optimize brand positioning, and make sure that clinical developments align with the real-world decision-making processes of physicians and the needs of patients.

How large is the global oncology market research industry?

While exact figures for the oncology-specific segment are rarely isolated, it is a significant and growing portion of the broader healthcare market research industry. The growth is driven by the rapid pace of oncology drug development and the increasing importance of patient-centricity in pharmaceutical brand strategy across worldwide markets.

What specialized services do oncology market research firms provide?

Specialized services include patient journey mapping, physician perception studies, competitive intelligence, pipeline forecasting, and behavioral science-led nudging. These firms also provide high-level analytical support, such as segmentation and demand forecasting, specifically tailored to the unique regulatory and clinical environments of the oncology sector.

How to find oncology market research experts for clinical trials?

Finding experts for clinical trials involves looking for firms with established panels of verified oncologists and healthcare professionals. You should evaluate their history of conducting research in relevant therapy areas and their ability to provide documented evidence of respondent credentialing and compliance with clinical research standards.

What are the key trends in oncology market research?

Key trends include the integration of behavioral science to understand complex decision-making, the use of AI for data quality and fraud detection, and a stronger focus on patient-centricity. There is also an increasing shift toward longitudinal tracking studies that follow patients and physicians throughout the entire product lifecycle.

Why is verification important in oncology market research?

Verification is critical because the data often influences multi-million dollar business decisions regarding drug development and market entry. Using unverified respondents can lead to flawed data, incorrect market assumptions, and strategic failures, making it essential to confirm the credentials of medical professionals and the diagnostic history of patients.

Request research

Let's begin

Ready to hear what your market actually thinks?

Tell us the decision you're trying to make. We'll come back with what we'd field — usually within four business hours.

Brief us on a study